Elucid Names Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH Board Directors
Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has made two additions to its Board of Directors. The company named Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH as board directors.
These appointments will help guide Elucid as it accelerates its clinical research strategy, commercializes its flagship PlaqueIQ TM coronary plaque assessment technology, and continues development of its investigational FFR prediction model, based on PlaqueIQ. PlaqueIQ is the first and only FDA-cleared, non-invasive plaque analysis based on objective histology rather than subjective CCTA visual estimates. PlaqueIQ quantifies and classifies plaque morphology based on ground-truth histology, the gold standard for characterization of plaques. The software is designed to help physicians prioritize and personalize treatment based on actual disease, rather than population-based risk.
An experienced medical technology executive and clinical expert, Dr. Kuntz is former senior vice president and chief medical and scientific officer of Medtronic plc. Prior to joining Medtronic, he was the founder and chief scientific officer of the Harvard Clinical Research Institute (HCRI), a university-based contract research organization that coordinates National Institutes of Health (NIH) and industry clinical trials with the U.S. Food and Drug Administration (FDA). Dr. Kuntz has directed several multicenter clinical trials and has authored more than 250 original publications. Dr. Kuntz was an associate professor of Medicine at Harvard Medical School, chief of the division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women's Hospital in Boston.
Dr. Feinglass is a managing director at Manatt Health working across the business, medical, and policy needs of health systems, life sciences, medical device, digital health and diagnostic companies globally. A global leader in health care, Dr. Feinglass has served as an executive and chief medical officer in large multi-national life sciences corporations including Danaher and Zimmer-Biomet. In parallel, she has driven policy changes alongside senior government officials around the world to influence health policy, regulation, and access. A former regulator at U.S. Centers for Medicare and Medicaid Services (CMS) and commander in the U.S. Public Health Service with extensive regulatory and legislative experience, Dr. Feinglass is on faculty at the John's Hopkins Bloomberg School of Public Health, Department of Mental Health and is a member of the Board of Directors of Sandoz AG.
'We are honored that Dr. Richard E. Kuntz and Dr. Shamiram Feinglass have joined Elucid's Board of Directors,' said Elucid CEO Kelly Huang, PhD. 'Rick lends an important and experienced interventional cardiology view, as well as expertise in clinical trial strategy and execution, and product innovation strategy. Coupled with Shami's unparalleled expertise in market access, policy making, and regulatory strategy, the two will be invaluable as we push forward our vision of a future where cardiac care is personalized, precision patient care versus risk factor and population-based care.'
About Elucid
Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root cause of cardiovascular disease. The company's PlaqueIQ TM image analysis software is designed to help physicians prioritize and personalize treatment based on actual disease, rather than population-based risk of disease. PlaqueIQ includes the only FDA-cleared computed tomography angiography (CTA) algorithm that objectively quantifies plaque morphology validated against ground truth histology, the gold standard for characterization of plaque, as indicated by renowned pathologists. PlaqueIQ equips physicians with critical information regarding the type and amount of plaque in arteries that can lead to heart attack and stroke. Elucid is also pursuing an indication for FFR CT, derived from its plaque algorithm, to help identify coronary blockages and the extent of ischemia non-invasively. For more information, visit elucid.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250717174768/en/
CONTACT: Media Contact:
Sam Choinski
Pazanga Health Communications
(860) 301-5058
[email protected]
KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA CANADA
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES TECHNOLOGY HEALTH TECHNOLOGY SOFTWARE ARTIFICIAL INTELLIGENCE CARDIOLOGY
SOURCE: Elucid
Copyright Business Wire 2025.
PUB: 07/17/2025 07:05 AM/DISC: 07/17/2025 07:05 AM
http://www.businesswire.com/news/home/20250717174768/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Trump pauses export controls to bolster China trade deal, FT says
(Reuters) -The U.S. has paused curbs on tech exports to China to avoid disrupting trade talks with Beijing and support President Donald Trump's efforts to secure a meeting with President Xi Jinping this year, the Financial Times said on Monday. The industry and security bureau of the Commerce Department, which oversees export controls, has been told in recent months to avoid tough moves on China, the newspaper said, citing current and former officials. Reuters could not immediately verify the report. The White House and the department did not respond to Reuters' requests for comment outside business hours. Top U.S. and Chinese economic officials are set to resume talks in Stockholm on Monday to tackle longstanding economic disputes at the centre of a trade war between the world's top two economies. Tech giant Nvidia said this month it would resume sales of its H20 graphics processing units (GPU) to China, reversing an export curb the Trump administration imposed in April to keep advanced AI chips out of Chinese hands over national security concerns. The planned resumption was part of U.S. negotiations on rare earths and magnets, Commerce Secretary Howard Lutnick has said. The paper said 20 security experts and former officials, including former deputy US national security adviser Matt Pottinger, will write on Monday to Lutnick to voice concern, however. "This move represents a strategic misstep that endangers the United States' economic and military edge in artificial intelligence," they write in the letter, it added.
Entrepreneur
24 minutes ago
- Entrepreneur
UBQT Named Official Networking Platform for Step Conference San Francisco
You're reading Entrepreneur Middle East, an international franchise of Entrepreneur Media. Step Conference, a tech event for emerging markets, has partnered with UBQT, an AI-powered platform enabling real-life catchups within professional communities, as its official networking platform for the upcoming San Francisco edition. UBQT will empower Step San Francisco (Step SF) attendees to plan professional catchups, connect across borders, and deepen relationships throughout the event. UBQT, co-founded by Lara Varjabedian, Jonathan L. Hasson, and I.Q. Sayed, is the tool of choice for community owners, event organisers, and corporates looking to drive engagement and social cohesion through meaningful in-person connections. With features that allow attendees to sync diaries, receive smart nudges when peers are nearby, and streamline spontaneous or planned catchups, UBQT ensures real-life moments are easy and frequent. This partnership reflects Step SF's commitment to building authentic, cross-border collaboration, and UBQT's mission to tech-enable communities to unlock social capital. Finding the 'human' in a digital world Screen fatigue and digital fragmentation has left many of us craving the energy and spontaneity of real-life interaction. UBQT empowers this, allowing organisations to drive high-quality engagement in real life. Attendees and speakers at Step SF will: - Receive smart catchup recommendations when someone from your network is nearby or planning to be nearby soon, - Align calendars and travel plans to coordinate catchups, - Make the most of the event by discovering the most relevant fellow attendees - founders, investors and ecosystem enablers, - Stay connected with the community well beyond the event. "UBQT goes beyond simply enabling great networking at Step SF. It empowers our attendees to connect meaningfully, not just during the event, but well beyond it," said Ray Dargham, co-founder and CEO at Step. "It's not just another event app; it's a true community engagement platform. We're proud to bring this experience to our San Francisco network." Related: Nurturing Connections: UBQT Co-Founders Jonathan L. Hasson And Lara Varjabedian
Yahoo
41 minutes ago
- Yahoo
Sam Altman Says OpenAI Is Poised to Wipe Out Entire Categories of Human Jobs
OpenAI CEO Sam Altman is warning that entire job categories could be wiped out by artificial intelligence, echoing widespread concerns that the technology could have devastating effects on the human labor market. During his most recent trip to Washington, DC, Altman told Federal Reserve vice-chair for supervision Michelle Bowman that "some areas" in the job market will be "just like totally, totally gone" as they're replaced by AI agents. Altman identified customer support roles as a "category where I just say, you know what, when you call customer support, you're on target and AI, and that's fine." "Now you call one of these things and AI answers," he said. "It's like a super-smart, capable person. There's no phone tree, there's no transfers. It can do everything that any customer support agent at that company could do." The billionaire, who's unlikely to have had to personally speak to a customer support agent on the phone in quite some time, effectively threw humans under the bus during the remarks. "It does not make mistakes," he added. "It's very quick. You call once, the thing just happens, it's done." How close OpenAI's tech actually is to that goal is questionable. Critics say that AI tends to replace human labor with an alternative that's unreliable and prone to unexpected edge cases. There are also practical considerations: we've already seen companies getting huge amounts of negative attention for attempting to ditch human workers in favor of unproven AI. It's gotten to the point where companies are admitting that they're going back on their promises to ditch human workers. Fintech company Klarna CEO Sebastian Siemiatkowski, who previously boasted that an AI assistant would do the job of 700 people, ended up reversing course, announcing that "from a brand perspective... I just think it's so critical that you are clear to your customer that there will always be a human if you want." A study found last year that the majority of customers do not want companies to use AI for customer service. And who could blame them? Glaring problems plaguing currently available AI models mean the tech is causing chaos and frustration. Earlier this year, for instance, a customer found that they were getting mysteriously logged out by AI-powered software coding assistant, Cusor. An AI-powered customer support agent told them it was "expected behavior" under a new login policy — which turned out to be a hallucination by the glitchy AI. In short, Altman's imagining a future that doesn't exist yet, and may or may not actually materialize. But it's one he wants to see: as the leader of one of the most successful AI companies in the industry, he has plenty to gain. More on Altman: Behind the Scenes, Sam Altman Is Absolutely Furious Solve the daily Crossword
